Bionano Genomics (BNGO) Debt/EBITDA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
Debt/EBITDA | -0.10 | 0.60 | 3.25 | 0.84 | 0.11 | -0.11 | |||
Changes by years, y/y, % | -129% | -680% | +445% | -74% | -88% | -21.6% |
Bionano Genomics. Debt/EBITDA
Bionano Genomics. Debt/EBITDA, changes, %
Bionano Genomics (BNGO) Debt/EBITDA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
Debt/EBITDA | 0.24 | 0.06 | 0.05 | -0.05 | -0.11 | -0.11 | ||
Changes by years, y/y, % | -85% | -92% | -93% | -110% | -146% | |||
Changes by quarters, q/q, % | -49% | -74% | -26% | -199% | +144% |